IBDEI0GQ ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,343,0)
 ;;=CARDIOVASCULAR SYSTEM^3^31
 ;;^UTILITY(U,$J,358.4,344,0)
 ;;=DIGESTIVE SYSTEM^6^31
 ;;^UTILITY(U,$J,358.4,345,0)
 ;;=URINARY SYSTEM^25^31
 ;;^UTILITY(U,$J,358.4,346,0)
 ;;=MALE GENITAL SYSTEM^12^31
 ;;^UTILITY(U,$J,358.4,347,0)
 ;;=FEMALE GENITAL SYSTEM^8^31
 ;;^UTILITY(U,$J,358.4,348,0)
 ;;=NERVOUS SYSTEM^15^31
 ;;^UTILITY(U,$J,358.4,349,0)
 ;;=EYE & OCULAR ADNEXA^7^31
 ;;^UTILITY(U,$J,358.4,350,0)
 ;;=AUDITORY SYSTEM^1^31
 ;;^UTILITY(U,$J,358.4,351,0)
 ;;=REPAIR-INTER SCALP/NECK/TRNK/EXTREM^19^31
 ;;^UTILITY(U,$J,358.4,352,0)
 ;;=REPAIR-INTER FACE/EARS/EYELID/NOSE/LIP^17^31
 ;;^UTILITY(U,$J,358.4,353,0)
 ;;=REPAIR-INTER HANDS/FEET/EXT GENITALIA^18^31
 ;;^UTILITY(U,$J,358.4,354,0)
 ;;=BURNS^2^31
 ;;^UTILITY(U,$J,358.4,355,0)
 ;;=DESTRUCTION BENIGN LESIONS^5^31
 ;;^UTILITY(U,$J,358.4,356,0)
 ;;=EMERGENCY DEPT VISIT^1^32
 ;;^UTILITY(U,$J,358.4,357,0)
 ;;=CRITICAL CARE/EMERGENT SERVICES^2^32
 ;;^UTILITY(U,$J,358.4,358,0)
 ;;=CARDIOVASCULAR^1^33
 ;;^UTILITY(U,$J,358.4,359,0)
 ;;=ENDOCRINE/METABOLIC^5^33
 ;;^UTILITY(U,$J,358.4,360,0)
 ;;=PULMONARY^18^33
 ;;^UTILITY(U,$J,358.4,361,0)
 ;;=EENT^4^33
 ;;^UTILITY(U,$J,358.4,362,0)
 ;;=MUSCULOSKELETAL^13^33
 ;;^UTILITY(U,$J,358.4,363,0)
 ;;=NEURO^14^33
 ;;^UTILITY(U,$J,358.4,364,0)
 ;;=MENTAL HEALTH^12^33
 ;;^UTILITY(U,$J,358.4,365,0)
 ;;=GASTROENTEROLOGY^6^33
 ;;^UTILITY(U,$J,358.4,366,0)
 ;;=GU / RENAL^7^33
 ;;^UTILITY(U,$J,358.4,367,0)
 ;;=WOMEN'S HEALTH^21^33
 ;;^UTILITY(U,$J,358.4,368,0)
 ;;=HEMATOLOGY/ONCOLOGY^8^33
 ;;^UTILITY(U,$J,358.4,369,0)
 ;;=INFECTIOUS DISEASE^10^33
 ;;^UTILITY(U,$J,358.4,370,0)
 ;;=DERMATOLOGY^3^33
 ;;^UTILITY(U,$J,358.4,371,0)
 ;;=HISTORY OF ILLNESS^9^33
 ;;^UTILITY(U,$J,358.4,372,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^17^33
 ;;^UTILITY(U,$J,358.4,373,0)
 ;;=INJURY/TRAUMA^11^33
 ;;^UTILITY(U,$J,358.4,374,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^20^33
 ;;^UTILITY(U,$J,358.4,375,0)
 ;;=SEXUAL TRAUMA^19^33
 ;;^UTILITY(U,$J,358.4,376,0)
 ;;=PAIN^16^33
 ;;^UTILITY(U,$J,358.4,377,0)
 ;;=OTHER REASONS^15^33
 ;;^UTILITY(U,$J,358.4,378,0)
 ;;=CAUSES OF INJURY (SECONDARY ONLY)^2^33
 ;;^UTILITY(U,$J,358.4,379,0)
 ;;=NEW PATIENT^3^34
 ;;^UTILITY(U,$J,358.4,380,0)
 ;;=ESTABLISHED PATIENT^2^34
 ;;^UTILITY(U,$J,358.4,381,0)
 ;;=CONSULTATIONS^4^34
 ;;^UTILITY(U,$J,358.4,382,0)
 ;;=EYE CODES^1^34
 ;;^UTILITY(U,$J,358.4,383,0)
 ;;=REFRACTION^7^35
 ;;^UTILITY(U,$J,358.4,384,0)
 ;;=GLASSES/CONTACT LENSES^2^35
 ;;^UTILITY(U,$J,358.4,385,0)
 ;;=SPECIAL OPHTHALMIC SERVICES^9^35
 ;;^UTILITY(U,$J,358.4,386,0)
 ;;=PROCEDURES^6^35
 ;;^UTILITY(U,$J,358.4,387,0)
 ;;=LASER PROCEDURES^4^35
 ;;^UTILITY(U,$J,358.4,388,0)
 ;;=RETINA PROCEDURES^8^35
 ;;^UTILITY(U,$J,358.4,389,0)
 ;;=MEDICATIONS^5^35
 ;;^UTILITY(U,$J,358.4,390,0)
 ;;=INTRAVITREAL INJECTIONS^3^35
 ;;^UTILITY(U,$J,358.4,391,0)
 ;;=EDUCATION/COUNSELING^1^35
 ;;^UTILITY(U,$J,358.4,392,0)
 ;;=ORBIT/EYELID/LACRIMAL^8^36
 ;;^UTILITY(U,$J,358.4,393,0)
 ;;=ANTERIOR SEGMENT/LACRIMAL^2^36
 ;;^UTILITY(U,$J,358.4,394,0)
 ;;=LENS/CATARACT^5^36
 ;;^UTILITY(U,$J,358.4,395,0)
 ;;=RETINA/VITREOUS/CHOROID^9^36
 ;;^UTILITY(U,$J,358.4,396,0)
 ;;=NEUROLOGIC EYE DISEASE^7^36
 ;;^UTILITY(U,$J,358.4,397,0)
 ;;=MEDICAL/SYSTEMIC/TRAUMA/OTHER^6^36
 ;;^UTILITY(U,$J,358.4,398,0)
 ;;=GLAUCOMA^3^36
 ;;^UTILITY(U,$J,358.4,399,0)
 ;;=STRABISMUS^10^36
 ;;^UTILITY(U,$J,358.4,400,0)
 ;;=INFECTIONS/INFLAMMATION/CONJUNCTIVA^4^36
 ;;^UTILITY(U,$J,358.4,401,0)
 ;;=MOST COMMON^1^36
 ;;^UTILITY(U,$J,358.4,402,0)
 ;;=ORBIT/EYELID/LACRIMAL^8^37
 ;;^UTILITY(U,$J,358.4,403,0)
 ;;=ANTERIOR SEGMENT/LACRIMAL^2^37
 ;;^UTILITY(U,$J,358.4,404,0)
 ;;=LENS/CATARACT^5^37
 ;;^UTILITY(U,$J,358.4,405,0)
 ;;=RETINA/VITREOUS/CHOROID^9^37
 ;;^UTILITY(U,$J,358.4,406,0)
 ;;=NEUROLOGIC EYE DISEASE^7^37
 ;;^UTILITY(U,$J,358.4,407,0)
 ;;=MEDICAL/SYSTEMIC/TRAUMA/OTHER^6^37
 ;;^UTILITY(U,$J,358.4,408,0)
 ;;=GLAUCOMA^3^37
 ;;^UTILITY(U,$J,358.4,409,0)
 ;;=STRABISMUS^10^37
 ;;^UTILITY(U,$J,358.4,410,0)
 ;;=INFECTIONS/INFLAMMATION/CONJUNCTIVA^4^37
 ;;^UTILITY(U,$J,358.4,411,0)
 ;;=MOST COMMON^1^37
 ;;^UTILITY(U,$J,358.4,412,0)
 ;;=REFRACTION^1^38
 ;;^UTILITY(U,$J,358.4,413,0)
 ;;=GLASSES/CONTACT LENSES^2^38
 ;;^UTILITY(U,$J,358.4,414,0)
 ;;=SPECIAL OPHTHALMIC SERVICES^4^38
 ;;^UTILITY(U,$J,358.4,415,0)
 ;;=NEW PATIENT^2^39
 ;;^UTILITY(U,$J,358.4,416,0)
 ;;=ESTABLISHED PATIENT^1^39
 ;;^UTILITY(U,$J,358.4,417,0)
 ;;=CONSULTATIONS^3^39
 ;;^UTILITY(U,$J,358.4,418,0)
 ;;=BIOPSY/DEBRIDEMENT^1^40
 ;;^UTILITY(U,$J,358.4,419,0)
 ;;=I&D/ASPIRATION^4^40
 ;;^UTILITY(U,$J,358.4,420,0)
 ;;=DESTRUCT-BENIGN/PREMALIG LESIONS^2^40
 ;;^UTILITY(U,$J,358.4,421,0)
 ;;=SCOPES^5^40
 ;;^UTILITY(U,$J,358.4,422,0)
 ;;=EXCISION^3^40
 ;;^UTILITY(U,$J,358.4,423,0)
 ;;=POST-OP COMPLICATIONS^16^41
 ;;^UTILITY(U,$J,358.4,424,0)
 ;;=GENERAL/SIGNS & SYMPTOMS^6^41
 ;;^UTILITY(U,$J,358.4,425,0)
 ;;=GYN/BREAST^8^41
 ;;^UTILITY(U,$J,358.4,426,0)
 ;;=MALE BREAST^10^41
 ;;^UTILITY(U,$J,358.4,427,0)
 ;;=BENIGN LESIONS OF SKIN^3^41
 ;;^UTILITY(U,$J,358.4,428,0)
 ;;=MALIGNANT LESIONS OF SKIN^11^41
 ;;^UTILITY(U,$J,358.4,429,0)
 ;;=MELANOMA^12^41
 ;;^UTILITY(U,$J,358.4,430,0)
 ;;=LACERATIONS^9^41
 ;;^UTILITY(U,$J,358.4,431,0)
 ;;=MERKEL CELL CANCER^13^41
 ;;^UTILITY(U,$J,358.4,432,0)
 ;;=AFTERCARE POST SURGERY^2^41
 ;;^UTILITY(U,$J,358.4,433,0)
 ;;=CARDIOVASCULAR^4^41
 ;;^UTILITY(U,$J,358.4,434,0)
 ;;=ENT^5^41
 ;;^UTILITY(U,$J,358.4,435,0)
 ;;=ABDOMINAL PAIN^1^41
 ;;^UTILITY(U,$J,358.4,436,0)
 ;;=GI^7^41
 ;;^UTILITY(U,$J,358.4,437,0)
 ;;=RESPIRATORY^17^41
 ;;^UTILITY(U,$J,358.4,438,0)
 ;;=ORTHOPEDIC^14^41
 ;;^UTILITY(U,$J,358.4,439,0)
 ;;=PLASTIC SURGERY^15^41
 ;;^UTILITY(U,$J,358.4,440,0)
 ;;=UROLOGY^18^41
 ;;^UTILITY(U,$J,358.4,441,0)
 ;;=ESOPHAGUS^2^42
 ;;^UTILITY(U,$J,358.4,442,0)
 ;;=STOMACH/DUODENUM^7^42
 ;;^UTILITY(U,$J,358.4,443,0)
 ;;=SMALL BOWEL^6^42
 ;;^UTILITY(U,$J,358.4,444,0)
 ;;=LARGE BOWEL/RECTUM^3^42
 ;;^UTILITY(U,$J,358.4,445,0)
 ;;=SYMPTOMS^1^42
 ;;^UTILITY(U,$J,358.4,446,0)
 ;;=LIVER^4^42
 ;;^UTILITY(U,$J,358.4,447,0)
 ;;=PANCREAS^5^42
 ;;^UTILITY(U,$J,358.4,448,0)
 ;;=MISCELLANEOUS^8^42
 ;;^UTILITY(U,$J,358.4,449,0)
 ;;=ESOPHAGUS^4^43
 ;;^UTILITY(U,$J,358.4,450,0)
 ;;=SMALL INTESTINE ENDOSCOPY^9^43
 ;;^UTILITY(U,$J,358.4,451,0)
 ;;=SIGMOIDOSCOPY/PROCTOSIGMOIDOSCOPY^8^43
 ;;^UTILITY(U,$J,358.4,452,0)
 ;;=COLONOSCOPY^1^43
 ;;^UTILITY(U,$J,358.4,453,0)
 ;;=ERCP^2^43
 ;;^UTILITY(U,$J,358.4,454,0)
 ;;=G-TUBE^5^43
 ;;^UTILITY(U,$J,358.4,455,0)
 ;;=MISCELLANEOUS-PROCEDURES^7^43
 ;;^UTILITY(U,$J,358.4,456,0)
 ;;=IMMUNIZATIONS/INJECTIONS^6^43
 ;;^UTILITY(U,$J,358.4,457,0)
 ;;=ESOPHAGEAL MANOMETRY^3^43
 ;;^UTILITY(U,$J,358.4,458,0)
 ;;=NEW PATIENT^2^44
 ;;^UTILITY(U,$J,358.4,459,0)
 ;;=ESTABLISHED PATIENT^1^44
 ;;^UTILITY(U,$J,358.4,460,0)
 ;;=CONSULTATIONS^3^44
 ;;^UTILITY(U,$J,358.4,461,0)
 ;;=POST-OP FOLLOW-UP^4^44
 ;;^UTILITY(U,$J,358.4,462,0)
 ;;=ANEMIA^1^45
 ;;^UTILITY(U,$J,358.4,463,0)
 ;;=COAGULATION DISORDERS^4^45
 ;;^UTILITY(U,$J,358.4,464,0)
 ;;=MYELOID NEOPLASMS & DISORDERS^13^45
 ;;^UTILITY(U,$J,358.4,465,0)
 ;;=LYMPHOID NEOPLASMS^10^45
 ;;^UTILITY(U,$J,358.4,466,0)
 ;;=GI CANCER^7^45
 ;;^UTILITY(U,$J,358.4,467,0)
 ;;=HEAD, NECK & LUNG NEOPLASMS^8^45
 ;;^UTILITY(U,$J,358.4,468,0)
 ;;=MISC. NEOPLASMS^12^45
 ;;^UTILITY(U,$J,358.4,469,0)
 ;;=METASTATIC SITES^11^45
 ;;^UTILITY(U,$J,358.4,470,0)
 ;;=COUNSELING & SCREENING^5^45
 ;;^UTILITY(U,$J,358.4,471,0)
 ;;=HEMOGLOBINOPATHIES^9^45
 ;;^UTILITY(U,$J,358.4,472,0)
 ;;=GENITOURINARY NEOPLASMS^6^45
 ;;^UTILITY(U,$J,358.4,473,0)
 ;;=BREAST & GYN NEOPLASMS^3^45
 ;;^UTILITY(U,$J,358.4,474,0)
 ;;=ARTIFICIAL OPENING STATUS^2^45
 ;;^UTILITY(U,$J,358.4,475,0)
 ;;=PERSONAL HX OF CANCER^14^45
 ;;^UTILITY(U,$J,358.4,476,0)
 ;;=SPECIAL SERVICES^5^46
 ;;^UTILITY(U,$J,358.4,477,0)
 ;;=TREATMENT^4^46
 ;;^UTILITY(U,$J,358.4,478,0)
 ;;=MISCELLANEOUS^7^46
 ;;^UTILITY(U,$J,358.4,479,0)
 ;;=IMMUNIZATIONS^6^46
 ;;^UTILITY(U,$J,358.4,480,0)
 ;;=CHEMO ADMINISTRATION^1^46
 ;;^UTILITY(U,$J,358.4,481,0)
 ;;=CHEMO DRUGS^2^46
 ;;^UTILITY(U,$J,358.4,482,0)
 ;;=OTHER DRUGS^3^46
 ;;^UTILITY(U,$J,358.4,483,0)
 ;;=NEW PATIENT^2^47
 ;;^UTILITY(U,$J,358.4,484,0)
 ;;=ESTABLISHED PATIENT^1^47
 ;;^UTILITY(U,$J,358.4,485,0)
 ;;=CONSULTATIONS^3^47
 ;;^UTILITY(U,$J,358.4,486,0)
 ;;=POST OP^4^47
 ;;^UTILITY(U,$J,358.4,487,0)
 ;;=ESOPHAGUS^2^48
 ;;^UTILITY(U,$J,358.4,488,0)
 ;;=STOMACH/DUODENUM^8^48
 ;;^UTILITY(U,$J,358.4,489,0)
 ;;=SMALL BOWEL^7^48
 ;;^UTILITY(U,$J,358.4,490,0)
 ;;=LARGE BOWEL/RECTUM^4^48
 ;;^UTILITY(U,$J,358.4,491,0)
 ;;=SYMPTOMS^1^48
 ;;^UTILITY(U,$J,358.4,492,0)
 ;;=LIVER^5^48
 ;;^UTILITY(U,$J,358.4,493,0)
 ;;=PANCREAS^6^48
 ;;^UTILITY(U,$J,358.4,494,0)
 ;;=GALLBLADDER^3^48
 ;;^UTILITY(U,$J,358.4,495,0)
 ;;=ESOPHAGUS^3^49
 ;;^UTILITY(U,$J,358.4,496,0)
 ;;=SMALL INTESTINE ENDOSCOPY^8^49
 ;;^UTILITY(U,$J,358.4,497,0)
 ;;=SIGMOIDOSCOPY/PROCTOSIGMOIDOSCOPY^7^49
 ;;^UTILITY(U,$J,358.4,498,0)
 ;;=COLONOSCOPY^1^49
 ;;^UTILITY(U,$J,358.4,499,0)
 ;;=ERCP^2^49
 ;;^UTILITY(U,$J,358.4,500,0)
 ;;=G-TUBE^4^49
 ;;^UTILITY(U,$J,358.4,501,0)
 ;;=MISCELLANEOUS-PROCEDURES^6^49
 ;;^UTILITY(U,$J,358.4,502,0)
 ;;=IMMUNIZATIONS/INJECTIONS^5^49
 ;;^UTILITY(U,$J,358.4,503,0)
 ;;=NEW PATIENT^2^50
 ;;^UTILITY(U,$J,358.4,504,0)
 ;;=ESTABLISHED PATIENT^1^50
 ;;^UTILITY(U,$J,358.4,505,0)
 ;;=CONSULTATIONS^3^50
 ;;^UTILITY(U,$J,358.4,506,0)
 ;;=POST-OP FOLLOW-UP^4^50
 ;;^UTILITY(U,$J,358.4,507,0)
 ;;="A" MISC DIAGNOSIS^1^51
 ;;^UTILITY(U,$J,358.4,508,0)
 ;;="B" MISC DIAGNOSIS^4^51
 ;;^UTILITY(U,$J,358.4,509,0)
 ;;="C" MISC DIAGNOSIS^7^51
 ;;^UTILITY(U,$J,358.4,510,0)
 ;;="D" MISC DIAGNOSIS^8^51
 ;;^UTILITY(U,$J,358.4,511,0)
 ;;="E/F" MISC DIAGNOSIS^11^51
 ;;^UTILITY(U,$J,358.4,512,0)
 ;;="H" MISC DIAGNOSIS^13^51
 ;;^UTILITY(U,$J,358.4,513,0)
 ;;="I" MISC DIAGNOSIS^14^51
 ;;^UTILITY(U,$J,358.4,514,0)
 ;;="J/K/L" MISC DIAGNOSIS^15^51
 ;;^UTILITY(U,$J,358.4,515,0)
 ;;="M" MISC DIAGNOSIS^16^51
